Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
Graf Finckenstein Friedrich exercised options for 8,790 Iovance Biotherapeutics, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Graf Finckenstein Friedrich (Chief Medical Officer) exercised options for 8,790 Iovance Biotherapeutics, Inc. shares, leaving 136,274 shares. Filed Jun 3, 2026 (Form 4).
- Options exercised
- 8,790 shares
- Holding after
- 136,274 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Option exercise | 8,790 | 140,747 | Direct | |
| Jun 1, 2026 | Common Stock | Shares withheld for tax | 4,473 | US$3.96 | 136,274 | Direct |
Source
Related
- Iovance Biotherapeutics, Inc.
- Graf Finckenstein Friedrich
- Iovance Biotherapeutics, Inc. shareholders
- Form 4 · Graf Finckenstein Friedrich · Jun 9, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026